Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04200339 · ClinicalTrials.gov registry record
Adolescent SCreening To Help Eliminate Misuse
A clinical trial of Substance Use, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 810
- Enrollment target
- 1
- Study location
NCT04200339 is a study of Substance Use that has completed, run by Boston Children's Hospital. The registered enrollment target is 810 participants, below the 1,251-participant average among 88 other Substance Use trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04200339, a study of Substance Use, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 810 participants
- Enrollment target
- 1
- Study location
Study Summary
The specific aim of this study is to evaluate the performance of three substance use screening instruments (S2BI, BSTAD, and TAPS Tool) against a criterion standard of Diagnostic Statistical Manual - 5 (DSM-5) substance use disorder (SUD) diagnoses in an adolescent population.
Conditions Studied
Study Locations (1)
Massachusetts
- Boston Childrens Hopsital - Adolecents Substance Use and Addiction Program - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 810 participants |
| Start Date | 2020-07-21 |
| Est. Completion | 2022-02-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04200339
The ClinicalTrials.gov registry entry for NCT04200339 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 810 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,251-participant average among 88 other Substance Use trials with a reported enrollment target (35% lower). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Substance Use appearing as the primary indexed condition, and to 0 interventions.
NCT04200339 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04200339 about?
NCT04200339 is a clinical study titled "Adolescent SCreening To Help Eliminate Misuse". The specific aim of this study is to evaluate the performance of three substance use screening instruments (S2BI, BSTAD, and TAPS Tool) against a criterion standard of Diagnostic Statistical Manual - 5 (DSM-5) substance use disorder (SUD) diagnoses in an adolescent population.
What is the current status of trial NCT04200339?
This trial is currently completed. The enrollment target is 810 participants. The study started on 2020-07-21. Estimated completion is 2022-02-25.
What conditions does trial NCT04200339 study?
This clinical trial studies the following conditions: Substance Use.
Who is sponsoring clinical trial NCT04200339?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04200339 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Native Spirit: Significant Aim 3: Intervention
RECRUITING · NA
-
Parent SMART (Substance Misuse in Adolescents in Residential Treatment)
RECRUITING · NA
-
Cultural Adaptation of Drug Treatment for DJJ Youth
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.